About Day One Biopharmaceuticals, Inc (DAWN) data
Data as of April 15, 2026.
Day One Biopharmaceuticals, Inc (DAWN) has 6.58M shares sold short as of the latest FINRA settlement report on April 15, 2026. Short interest has decreased by 9.09% compared with the prior settlement. At the current average daily volume, covering all open short positions would take about 5.39 days (days to cover).
Frequently asked questions
What is the current short interest in DAWN?
As of the latest FINRA settlement dated April 15, 2026, DAWN had approximately 6,579,076 shares sold short. Short interest data is reported by FINRA twice per month.
How much does it cost to short DAWN?
The latest borrow fee (cost to borrow) for DAWN is 0.98% per year, based on IBKR data. Fees can change throughout the trading day as shares are borrowed and returned.
What is the days to cover ratio for DAWN?
Days to cover for DAWN is approximately 5.39 days. This estimates how many trading days it would take short sellers to buy back all outstanding short shares at the current average daily volume.
Is DAWN a short squeeze candidate?
A squeeze needs shorts that are hard to close. DAWN trades about 1,221,556 shares a day and would take roughly 5.39 days to unwind current short positions, at a current borrow fee of 0.98%. Higher days-to-cover and a rising borrow fee together are the setup to watch; neither alone is enough.